Table I.

Erythrodermic LC reported in the literature

Study	Patient age (y), sex	Leukemia subtype	Treatment	Erythroderma at presentation	BSA involved	Patient outcome
Su et al, 19849∗	NR	Chronic lymphocytic leukemia	NR	Yes	NR	NR
Jeong et al, 20097	82, male	Small cell variant of T-cell prolymphocytic leukemia	Oral fludarabine and prednisone	Yes	100% †	Death within 2 wks of chemotherapy initiation
Raj et al, 20118	75, male	Chronic myeloid leukemia	Imatinib	Yes	NR	Resolution within 1 mo of imatinib treatment
Novoa et al, 20155	65, female	Pre–B-cell acute lymphoblastic leukemia	Hospice care	No	70%	Death
Current case, 2018	50, female	AML	Cytarabine, HSCT	No	70%	Resolution within 2 wks of cytarabine reinduction

HSCT, Hematopoietic stem cell transplant; NR, not reported.

^∗Su et al describe 2 cases of erythroderma in patients with CLL as a part of a case series. It is not explicitly described whether the erythroderma was caused by leukemic infiltration of the skin or if it was related to the underlying leukemia.

^†Jeong et al describe involvement of the whole body although do not explicitly quantify the BSA involvement.